Tuesday, December 2, 2014

OncoMed starts dosing in Phase II trial of lung cancer drug tarextumab

… (OMP-59R5), to treat small cell lung cancer (SCLC). Tarextumab is currently being … , in pancreatic and non-small cell lung cancer. "Our aim is to …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)